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Introduction
•

•

•
•

The heart balances the supply and
demand of oxygen in the body by
pumping oxygenated blood through
the vasculature.
Congestive heart failure (CHF) is
the heart’s inability to eject blood
in sufficient amounts to maintain
the oxygen needs of bodily tissues
(Nagelhout et al., 2022)
CHF results in various
complications resulting from excess
fluid retention.
The New York Heart Association
(NYHA) and the American College
of Cardiology/American Heart
Accosiation provide classifications
and stages of heart failure (see
Figure 1)

Sings & Symptoms
•
•
•
•
•
•
•
•
•
•
•

Shortness of breath with activity or
when lying down
Fatigue and weakness
Swelling in the legs, ankles, and feet
Rapid or irregular heartbeat
Exercise intolerance
Cough, wheezing,
White or pink-tinged mucus
Swelling of the abdomen
Rapid weight gain from fluid
retention
Decreased alertness and problems
concentrating
Chest pain if heart failure is caused
by a myocardial infarction

Risk Factors
•

•

•
•
•
•

•
•
•

•
•

Coronary artery disease (CAD) –
weakens the heart as the narrowed
arteries cannot supply oxygen-rich
blood to meet myocardial oxygen
demands
Heart attack – a form of CAD that
occurs acutely; may result in
damage to the heart muscle leading
to impaired contractility
Heart valve disease – improper
valve function such as aortic
stenosis can impede blood flow.
Hypertension – increases the
workload of the heart
Congenital heart disease –
structural deformities from birth
can cause impaired heart function.
Irregular heartbeats – chronic
arrhythmias such as atrial
fibrillation can increase the
workload of the heart and lead to
heart failure
Diabetes – increases the risk of
CAD and hypertension
Sleep apnea – inadequate supply of
oxygen can cause arrhythmias
Obesity - overweight people have a
higher risk of developing diabetes,
hypertension, and heart
complications
Viruses – certain viruses can
damage cardiac muscle
Unhealthy behaviors - excessive
alcohol use, smoking, and an
unhealthy diet all can lead to heart
failure
(Mayo Clinic, 2022)

•
•

•
•
•

•

•
•

•

(Mayo Clinic, 2022)

Don’t smoke
Regular physical exercise
Reducing and managing stress
Eating healthy foods
Controlling conditions such as
hypertension and diabetes
Adhering to prescribed
medications
(CDC, 2020)

Class I

No limitation of phy;ical actMty, ordinary pt-r,,,kal activity
does not cause undue fatigue, palpitation, dyspnea

Class II

Slight lrTlitation of physical activity: comfortable at rest: Stage B
ordinary physical activity results in fatigue. palpitation.
<fyspnea

Developed structural heart disease that is strongly
associated with the development of HF. but without
signs or symptoms

Class Il l

Marked limitation of physical activity; comfortable
at rest; less than ordinary activity results in fatigue,
palpitation, or dyspnea

Stage C

Symptomatic HF associated with underlying structural
heart disease

Unable to carry on any physical activity without
discomfort; symptoms of HF at rest: if any physical
activity is undertaken. discomfort increases

Stage D

Class IV

ACC = ..American Col!eze of CardiolO()l:AHA

Figure 1 (Geogilis, 2017)

Stage A

•

Around 5.4 million people in the
United States have CHF (Wang et al.,
2021)
Prevelence of HF is about 1-2% and
increases to around 10% in people
ober 70 years old (Altukhays et al.,
2022)
40% of people over the age of 85 have
heart failure (Nagelhout et al., 2020)
It is estimated that 8 million people
will have heart failure by 2030
(Nagelhout et al., 2022)
Yearly national healthcare costs
associated with CHF are nearly $31
billion (including health care services,
medications, and missed work)
(Altukhays et al., 2022)
Worldwide yearly healthcare costs
associated with CHF are estimated to
be around $160 billion (Zhang et al.,
2022)
5-year mortality rate with CHF
diagnosis is 50% (Zhang et al., 2022)
In 2018, 379,800 death certificates in
the United States mentioned heart
failure (CDC, 2020)

CONGESTIVE HEART FAILURE
•

HEART
FAILURE

•
Reduced volume
of oxygen rich blood
pumped to body

•
Dilated ventride

Enlarged heart
Chest congestion

swelling in legs and feet
Edema

Pathophysiology
•

•

Heart failure is a complex syndrome that results from any heart dysfunction that
causes either an inadequate amount of filling or ejection of blood to meet the oxygen
demands of the body (Malik et al., 2022)
Heart failure can be diastolic or systolic and classified based on left ventricular ejection
fraction (LVEF):
- Diastolic heart failure results from stiffened ventricles that cannot relax enough
for adequate filling, while systolic heart failure results from impaired left
ventricle contraction resulting in decreased perfusion (see Figure 3)
(Banner Health, 2022).

stiucturnl or functional aboomiaity: oo ~ or symptoms

=hnerican l--lea,-t Association; HF = heart faiU'e: NYHA =New York 1--ieart Associat1on.

Excess fluid around lungs
Shortness of breath

Figure 2 – acquired from https;//www.istockphoto.com

At high risk for the development of HF; no identified

Advanced structural heart disease and marked symptoms of HF at rest despite maximal medical therapy

Heart failure increases the risk of
atrial fibrillation 10-fold, 1/3 of CHF
patients have atrial fibrillation
(Farmakis et al., 2020).
Patients with CHF have higher rates
of pulmonary edema and effusions
that are mainly caused by left
ventricular diastolic function (Li et
al., 2022)
Reduced renal perfusion from heart
failure can cause kidney injury,
leading to kidney failure and dialysis
if untreated (CDC, 2020)
”Heart failure is a major independent
predictor of adverse perioperative
outcomes in noncardiac surgery…in
patients with CHF and renal failure
undergoing emergency surgery,
mortality rates as high as 76% have
been reported “ (Nagelhout et al.,
2022, p. 195)

•
•
•
•
•
•
•
•
•

•

•

•

Diuretics, Beta-blockers, angiotensinconverting enzyme inhibitors,
angiotensin receptor blockers,
angiotensin receptor neprilysin
inhibitors, hydralazine plus nitrate,
digoxin, and aldosterone antagonists
all have documented survival
benefits (Malik et al., 2022)
Medication compliance, reducing
sodium in the diet, and fluid
restrictions.
In septic patients with heart failure,
utilizing a >30 mL/Kg fluid bolus
may reduce hospital stay mortality
(Acharya et al., 2021).
Device therapy such as an
implantable cardioverterdefibrillator (ICD) to prevent sudden
death resulting from fatal
arrhythmias (Berlinger et al., 2020)

Relieving symptoms of fluid retention
Alleviating anxiety and decreasing
fatigue
Promoting physical exercise
Encouraging medication compliance
Identifying and decreasing adverse
effects of treatments
Education about dietary restrictions
and modifications
Education about patient selfmonitoring of symptoms
Education about daily weight
monitoring
Education on when to seek help:
worsening symptoms of fluid
overload and hypoxia, uncontrolled
tachycardia, sustained irregular heart
rhythm, change in mental status, and
decreased urine output despite
diuretics
(Malik et al., 2022)

Treatment
•

Prevention
•
•
•
•
•

Nursing Care

Complications

Clinical Significance

Conclusion
•
•

•

•
•

•

CHF affects millions of people in the
United States and across the globe.
CHF is a complex pathophysiological
process that results in various
complications related to excess fluid
retention.
Classifications and stages of heart
failure provide a framework for
orienting syndrome progression.
Patients may take actions to lower
their risk of CHF, such as diet
modifications and exercise.
“Treatment with ACE inhibitors and
beta-blockers has led to a significant
improvement in the prognosis of
heart failure patients”
(Berlinger et al., 2020, p. 380)
Nursing implications and
interventions focus on fluid retention
education, management, and
treatment.

- Heart failure is usually classified “according to left ventricular ejection
fraction (LVEF) into heart failure with reduced ejection fraction (LVEF 40% or
less), known as HFrEF, and heart failure with preserved ejection fraction (LVEF
greater than 40%); known as HFpEF.” (Malik et al., 2022 p. 1)
•
•

The final stage of cardiac problems is usually CHF, when fluid backs up from the heart’s
inability to pump sufficiently (Altukhays et al., 2022)
CHF is “an abnormality of the myocardial function responsible for failure of the heart to
pump blood at a rate commensurate with the requirements of the metabolizing
tissue...a condition in which the heart fails to maintain an output sufficient for the
needs of the body and the cellular respiration becomes impaired” (Dhadwad et al.,
2020, p. 37).

Systolic Dysfunction

Normal

Figure 3 – acquired from https;//www.istockphoto.com

Diastolic Dysfunction
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